期刊文献+

取消药品加成政策对中国58家县级公立医院收入结构影响分析 被引量:5

Impact of the Zero-markup Drug Policy on Income Structure in 58 County Hospitals in China
下载PDF
导出
摘要 目的:评价取消药品加成政策实施效果,为完善中国取消药品加成政策提供参考。方法:数据来源于58家县级公立医院的问卷调查和2011—2015年中国县域统计年鉴和政府工作报告,通过固定效应面板回归,对样本县级公立医院年度收入情况及其影响因素进行分析。结果:实施取消药品加成政策的样本医院逐年增多,到2015年底达42家,占样本医院的72.4%;样本医院的总收入、业务收入和药品收入均随时间显著增长(P<0.01);取消药品加成政策使样本医院的总收入、财政补助收入和业务收入分别增加了6.7%、23.9%和11.0%(P<0.05),但对药品收入影响不显著。结论:取消药品加成政策有利于提高医院技术劳务性收入的比重、降低药品收入的比重,从而有利于医药分开的推进;但存在政策落实不到位的问题,仍需多种配套政策共同推进。 Objective:To assess the effect of zero-markup drug policy on annual income in county hospitals,thus,provide reference for policy makers to improve this policy.Methods:Data were collected through questionnaires from 58 county hospitals,and China Statistical Yearbook(County-Level)and Report on the Work of the Government from 2011 to 2015 were used in this study.Fixed-effects panel data analysis was used to evaluate the effect and influential factors of all kinds of annual income.Results:The implementation of zero-markup drug policy increased year by year.And by the end of 2015,42 hospitals accounted for 72.4%of the sample hospital have applied this policy.The total income,financial income and business income of the sample hospitals increased by 6.69%,23.9%and 11.0%after the implementation of zero-markup drug policy,respectively(P<0.05).However,the effect on drug income was not significant.Conclusion:The zero-markup drug policy contributes to cutting off the excessive drug income.However,it is difficult to be implemented zero-markup drug policy in China,therefore calling for a synchronous implementation of other policies.
出处 《药品评价》 CAS 2018年第6期18-21,33,共5页 Drug Evaluation
关键词 取消药品加成政策 县级公立医院 收入结构 中国 Zero-markup Drug Policy County Hospitals Income China
  • 相关文献

参考文献10

二级参考文献105

  • 1马丽平,吴奇飞.公立医院改革模式的回顾与反思——兼论公立医院套用国企改革模式的理论缺陷[J].中国卫生经济,2006,25(2):16-19. 被引量:26
  • 2姜海珊.新农合制度下医疗服务利用研究[M]{H}北京:知识产权出版社,201383-97.
  • 3巴蒂 H.巴尔塔基.面板数据计量经济分析[M]{H}北京:机械工业出版社,20105-8.
  • 4汉密尔顿.应用 Stata做统计分析[M]{H}重庆:重庆大学出版社,2009166-169.
  • 5郝模.医药卫生改革相关政策问题研究[M]{H}北京:科学出版社,200970-76.
  • 6杜乐勋.我国卫生总费用流向的概略分析和政策建议[J].中国卫生经济,2008,27(1):19-20. 被引量:14
  • 7Eichenberger P M, Lampert M L, Kahmann I V, et al. Classification of Drug-related Problems with NewPrescriptions usin'g a Modified PCNE Classification System[J]. Pharm World Sci, 2010, 32 ( 3 ) : 362-372.
  • 8Paulino E I, Bouvy M L, Gastelurrutia M A, et al. Drug Related Problems Identified by European Community Pharmacists in Patients Discharged from Hospital[J]. Pharm WoAd Sci, 2004, 26 ( 6 ) : 353-360.
  • 9Granas A G, Berg C, Hjellvik V, et al. Evaluating Categorisation and Clinical Relevance of Drug-related Problems in Medication Reviews[J]. Pharm World Sci, 2010, 32 ( 3 ) : 394-403.
  • 10Stafford A C, Tenni P C, Peterson G M, et al. Drug-related Problems Identified in Medication Rreviews by Australian Pharmacists[J]. Pharm World Sci, 2009, 31 ( 2 ) : 216-223.

共引文献200

同被引文献63

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部